Fusion Antibodies, an antibody humanization and cell line development CRO, have today announced the further preclinical development of Fsn1006h bispecific antibody and the granting of a European patent for the same. Fusion’s Fsn1006h antibody has been awarded European Patent No EP2281001 (IP Title: Anti-AREG/HB-EGF Antibodies and Treatment). The patent relates to the sequence of the CDRs of […]
Check out our company’s profile in the summer edition of European Biopharmaceutical Review. You can read a digital copy via http://flk.bz/W38U European Biopharmaceutical Review (EBR) is a quarterly magazine dedicated to the biopharmaceutical industry and biotechnology sector as a whole. EBR provides detailed articles and reviews combined with insightful interviews and opinion pieces. EBR offers the […]
Leading UK contract research organisation and antibody humanization specialist, Fusion Antibodies, has been shortlisted for a prestigious Irish Times InterTradeIreland Innovation Award. Leading UK contract research organisation and antibody humanization specialist, Fusion Antibodies, has been shortlisted for a prestigious Irish Times InterTradeIreland Innovation Award. The Belfast based company was among 18 finalists announced in the […]
Fusion Antibodies and ISCA diagnostics are announcing successful development of a humanized version of ISCA Diagnostic’s Aspergillus-specific monoclonal antibody JF5. The project has taken place over the past 10 months and today marks its successful completion. Fusion Antibodies is happy to announce the successful completion of the humanization of the Aspergillus-specific monoclonal antibody JF5. The […]
FUSION ANTIBODIES DEVELOP HIGH EXPRESSION LEVEL STABLE CELL LINE FOR ISCA DIAGNOSTICS Fusion Antibodies Develop High Expression Level Stable Cell Line for ISCA Diagnostics Fusion Antibodies and ISCA diagnostics are happy to announce another successful project – development of stable cell line expressing a humanized version of ISCA Diagnostic’s Aspergillus-specific monoclonal antibody JF5. The cell […]
In 2001, Fusion Antibodies emerged from Queen’s University in Belfast. We are happy to still be working together in the field of novel medicine. Queen’s University Belfast is a member of the Russell Group of 24 leading UK research-intensive universities, providing world-class education underpinned by world-class research. Founded as Queen’s College in 1845, it became a university […]
